Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy
Journal of Clinical Oncology - United States
doi 10.1200/jco.2006.09.7097
Full Text
Open PDFAbstract
Available in full text
Date
August 10, 2007
Authors
Publisher
American Society of Clinical Oncology (ASCO)